Inventor · disambiguated record
Honglin Li
Also filed as: LI HONGLIN
11 granted patents·8 pending applications·29 citations·filing 2010–2023
82Inventor score
Files withUNIV EAST CHINA SCIENCE & TECH12FUTUREWEI TECHNOLOGIES INC1JINGDONG TECHNOLOGY INFORMATION TECHNOLOGY CO LTD1PENG XIAOJUN1TAO PHARMACEUTICAL SUZHOU CO LTD1
Top patents by PatentIndex Score
19 records- 0189US10033595B2System and method for mobile network function virtualizationFUTUREWEI TECHNOLOGIES INC·Filed 2014·Granted Jul 24, 2018·24 cites·15 claims
- 0271US8962339B2Fluorescent probe compounds, preparation method and application thereofPENG XIAOJUN·Filed 2010·Granted Feb 24, 2015·2 cites·8 claims
- 0368US11590109B2Applications of novel thiazole derivative in treating virus infectionUNIV EAST CHINA SCIENCE & TECH·Filed 2017·Granted Feb 28, 2023·1 cites·6 claims
- 0466US10919869B2Thiazole derivative and applicationsUNIV EAST CHINA SCIENCE & TECH·Filed 2017·Granted Feb 16, 2021·1 cites·3 claims
- 0564US2025114762A1Biodegradable polymer microspheres and preparation method thereforWUHU WEIQIU NEW MATERIAL TECH CO LTD·Filed 2022·Application pending·0 cites
- 0663US2025388576A1Pyridonopyrimidine derivative as rsk inhibitor and use thereofUNIV EAST CHINA NORMAL·Filed 2023·Application pending·0 cites
- 0761US9670213B2Pteridine ketone derivative and applications thereof as EGFR, BLK, and FLT3 inhibitorUNIV EAST CHINA SCIENCE & TECH·Filed 2013·Granted Jun 6, 2017·1 cites·9 claims
- 0853US2023097553A1Anti-rna virus drug and application thereofUNIV EAST CHINA SCIENCE & TECH·Filed 2021·Application pending·0 cites
- 0950US2023190713A1Anti-rna virus drug and application thereofUNIV EAST CHINA SCIENCE & TECH·Filed 2021·Application pending·0 cites
- 1049US2023321103A1Compound for inhibiting mutant egfr and use thereofUNIV EAST CHINA SCIENCE & TECH·Filed 2021·Application pending·0 cites
- 1148US2025323893A1Multi-cluster access method and systemJINGDONG TECHNOLOGY INFORMATION TECHNOLOGY CO LTD·Filed 2023·Application pending·0 cites
- 1247US12180146B2Antihypertensive polyol compound and derivative thereofTAO PHARMACEUTICAL SUZHOU CO LTD·Filed 2020·Granted Dec 31, 2024·0 cites·3 claims
- 1345US2021155604A1Quinazoline compound serving as egfr triple mutation inhibitor and applications thereofUNIV EAST CHINA SCIENCE & TECH·Filed 2019·Application pending·0 cites
- 1443US8846627B2Method for treatment of malariaZHANG WEIDONG·Filed 2012·Granted Sep 30, 2014·0 cites·3 claims
- 1541US11306095B2Use of pteridinone derivative serving as EGFR inhibitorUNIV EAST CHINA SCIENCE & TECH·Filed 2016·Granted Apr 19, 2022·0 cites·11 claims
- 1641US2021179598A1Selective jak2 inhibitor and application thereofUNIV EAST CHINA SCIENCE & TECH·Filed 2019·Application pending·0 cites
- 1740US11534427B2Applications of novel thiazole derivative in treating inflammatory bowel diseasesUNIV EAST CHINA SCIENCE & TECH·Filed 2017·Granted Dec 27, 2022·0 cites·4 claims
- 1834US11464795B2Saponin compound targeting PD-1 and application thereofUNIV EAST CHINA SCIENCE & TECH·Filed 2018·Granted Oct 11, 2022·0 cites·2 claims
- 1933US10479798B2Six-membered ring benzo derivatives as DPP-4 inhibitor and use thereofUNIV EAST CHINA SCIENCE & TECH·Filed 2015·Granted Nov 19, 2019·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Honglin Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →